Estrogen, a hormone primarily involved in female reproductive health, has been linked to Alzheimer's disease (AD) and dementia. Research suggests that estrogen has neuroprotective properties, potentially reducing the risk of AD. It influences brain function by promoting synaptic plasticity, enhancing cerebral blood flow, and reducing inflammation. Postmenopausal women, who experience a significant drop in estrogen levels, show a higher incidence of AD, implying a connection between estrogen deficiency and cognitive decline. Hormone replacement therapy (HRT) has been explored as a preventive measure; however, its efficacy and safety remain controversial, with studies showing mixed results. Understanding estrogen's role in neuroprotection could lead to new therapeutic strategies for combating Alzheimer's and other dementias.
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Association between APOE allele prevalence and Alzheimer's disease risk in Southwestern Uganda
Frank Balikoowa, African Research Center for Ageing & Dementia, Uganda
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China